DOCETAXEL
| Brand name | DOCETAXEL |
|---|---|
| Active ingredient | DOCETAXEL |
| Strength | 160MG/8ML (20MG/ML) |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Modality | Small molecule |
| FDA approval | December 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9763880 | September 2033 | use U-2560 |
| 8940786 | September 2033 | product |
| 9308195 | September 2033 | product |
| 10842770 | August 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.